Cerus Corp (Cerus) is a biomedical products company with focus on developing and commercializing the Intercept blood system to enhance blood safety. The Intercept blood system targets and inactivates blood-borne pathogens in donated blood components intended for transfusion. The company's focused R&D activities, Intercept blood system technology and diverse geographical presence are its strengths, even as a history of losses is a cause for concern to Cerus. Collaborations and agreements, increasing healthcare expenditure, and the growing need for safe blood provide the company with immense growth opportunities. However, the competitive environment, lack of manufacturing facilities and safety paradigm are matters of concern to the company.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer